PMID int64 27.8M 36.2M | Title/Abstract stringlengths 7 10.7k | MeshTerms stringlengths 7 104 | SemanticTypes stringlengths 4 84 |
|---|---|---|---|
34,675,131 | variat patent ductus arteriosus treatment low birth weight infant patent ductus arteriosus pda treatment common among low birth weight vlbw infant given limit evid controversi exist regard treatment risk benefit studi describ pda treatment trend variat larg us multicent vlbw infant cohort | D019102 | T047;T184 |
34,675,130 | intervent improv chlamydia gonorrhea test among adolesc primari care rate chlamydia gonorrhea among adolesc continu rise aim evalu univers test program chlamydia gonorrhea improv test rate urban general pediatr clinic urban famili medicin clinic within system feder qualifi health care center evalu feasibl cost logist challeng expand implement across primari care clinic within feder qualifi health care center system | D011320;D015397 | T058;T080;T057 |
34,675,129 | mental health among uk univers staff postgradu student earli stage covid pandem characteris baselin king colleg london coronavirus health experi colleagu king cohort describ pattern probabl depress anxieti among staff postgradu research student larg uk univers aprilmay | D000437;D000086382 | T048;T047;T067 |
34,675,128 | histopatholog analysi vivo specimen recurr aneurysm coil embol aneurysm recurr coil embol remain challeng problem | D017542;D004621;D002532;D013345;D013927 | T190;T047;T061;T046 |
34,675,127 | accept hygien face cover social distanc intervent prevent exacerb peopl live airway diseas intervent prevent spread sar cov associ substanti reduct exacerb airway diseas like reduc transmiss respiratori virus survey peopl airway diseas asthma bronchiectasi chronic obstruct pulmonari diseas gaug attitud intent toward continu measur covid pandem intend continu wear face mask indoor public space thought everyon requir influenza season women bronchiectasi older peopl general cautious respiratori virus infect control measur consid clinic guidelin public health recommend | D001987;D000086382;D012120 | T047;T067 |
34,675,126 | exposur inorgan particl paediatr sarcoidosi pediasarc studi inorgan antigen may contribut paediatr sarcoidosi thirti six patient match healthi control well group sickl cell diseas scd control answer environment questionnair patient indirect exposur inorgan particl coresid occup higher healthi scd control median score vs p p respect especi construct exposur metal dust talc abras reagent scour product wood fossil energi heat also link paediatr sarcoidosi studi support link miner environment exposur due adult coresid occup paediatr sarcoidosi | D016273;D012507 | T047;T037 |
34,675,124 | sufu haploinsuffici caus recognis neurodevelopment phenotyp mild end joubert syndrom spectrum joubert syndrom js recess inherit ciliopathi characteris congenit ocular motor apraxia coma development delay dd intellectu disabl ataxia multiorgan involv uniqu cerebellar brainstem malform js associ gene known diagnost yield report homozyg hypomorph missens variant sufu gene two famili mild js recent heterozyg truncat sufu variant identifi famili domin inherit coma occasion associ mild dd subtl cerebellar anomali | D000015;D002524;D005124;D008607;D052177 | T047;T184;T048;T019;T033 |
34,675,123 | notchnlc relat disord widen spectrum genotyp phenotyp correl ggc repeat expans untransl region notchnlc common causat factor neuron intranuclear inclus diseas niid asian expand ggc repeat identifi patient leukoencephalopathi essenti tremor et multipl system atrophi parkinson diseas pd amyotroph later sclerosi oculopharyngodist myopathi opdm herein review recent report notchnlc relat disord potenti diseas caus mechan found visual abnorm may notchnlc specif investig patient notchnlc mutat notchnlc ggc repeat expans rare identifi patient european ancestri wherea actual preval expans european patient may potenti higher report cgg repeat lrp gipc suggest screen european patient niid repeat size interrupt notchnlc ggc expans confer pleiotrop effect clinic phenotyp pure stabl et phenotyp may earli symptom niid ggc repeat notchnlc possibl give rise et associ may also exist intermedi length notchnlc ggc repeat expans patient affect pd et notchnlc opdm high resembl notchnlc niid two disord may variat singl neurodegen diseas may diseas caus upper limit size ggc repeat notchnlc repeat may non pathogen haploinsuffici notchnlc may primarili involv notchnlc relat disord toxic gain function mechan possibl drive pathogenesi neurodegener patient notchnlc associ disord | D019680 | T049 |
34,675,112 | f fdg pet improv baselin clinic predictor respons diffus larg b cell lymphoma hovon studi aim determin ad valu baselin metabol tumor volum mtv interim pet pet age adjust intern prognost index aaipi predict progress free surviv pfs diffus larg b cell lymphoma secondari object investig optim pet respons criteria use deauvill score ds quantit chang suv max suv max baselin pet observ pet scan cycl rituximab cyclophosphamid doxorubicin vincristin prednison administ wk interv intensifi rituximab first cycl r r chop method pet scan hovon hemato oncologi voor volwassenen nederland haemato oncolog foundat adult netherland random clinic trial eudract central review use ds cutoff addit suv max prespecifi cutoff baselin mtv measur multivari hazard ratio hr posit predict valu ppv negat predict valu npv obtain pfs result total pet scan review accord ds suv max baselin mtv avail patient npv pet rang pet respons criteria univari hr ppv better suv max respect ds respect aaipi suv max independ predict pfs hr respect ad mtv brought slight improv low low intermedi aaipi combin suv max patient yield npv combin high intermedi high aaipi suv max less yield ppv conclus studi diffus larg b cell lymphoma pet cycl r r chop ad predict valu aaipi pfs independ respons biomark multivari cox model extern valid suv max outperform ds pfs predict | D019788;D016403 | T130;T191;T109 |
34,675,110 | femal author nuclear medicin journal survey despit femin medic workforc women career perspect men nuclear medicin littl inform avail sex gap regard promin author posit scientif articl therefor purpos studi evalu recent trend sex distribut first last authorship articl publish nuclear medicin journal method conduct bibliometr analysi first last author sex articl publish nuclear medicin journal manuscript titl articl type journal impact factor date public first last name countri proven first last author note gender api softwar use determin author sex statist descript result women repres first author last author femal authorship increas articl articl relat increas p first author articl articl relat increas p last author pariti forecast first author last author femal authorship increas europ first author p last author p high rank journal first author p last author p journal rank last author p femal first last authorship rose origin articl p p respect case report p p respect regard collabor proport articl produc male first last author decreas favor femal first last author odd ratio p male first femal last author odd ratio p femal first male last author odd ratio p conclus femal first last authorship nuclear medicin journal increas substanti particular high rank journal europ origin articl case report male male collabor decreas favor collabor pariti foreseen decad | D009683;D010506 | T091;T170;T073 |
34,675,109 | histori prostat specif membran antigen theranost target prostat cancer cornerston role prostat cancer foundat prostat specif membran antigen psma credenti imag therapi theranost target detect treatment prostat cancer psma target pet imag molecular radiotherapi promis evolv technolog improv outcom prostat cancer patient anticip new era prostat cancer theranost articl review histori psma discoveri earli late stage clinic trial sinc prostat cancer foundat fund critic foundat psma research establish theranost revolut histori role prostat cancer foundat fund field discuss | D057285;D011471 | T091;T191;T061 |
34,675,108 | comparison exogen keton administr versus dietari carbohydr restrict myocardi glucos suppress crossov clinic trial ketogen diet kd standard care achiev myocardi glucos suppress mgs assess inflamm use f fdg pet howev failur suppress physiolog glucos uptak remain signific diagnost barrier although extend durat kd may effect exogen deliv keton may provid conveni reliabl day altern aim studi determin whether exogen keton administr noninferior kd achiev mgs whether serum hydroxybutyr bhb level predict mgs method keeto cross ketogen endogen versus exogen therapi myocardi glucos suppress crossov noninferior trial kd endogen ketosi versus keton ester ke exogen ketosi drink twenti healthi particip enrol arm weight base ke drink h kd h kd n complet arm primari outcom achiev complet mgs pet noninferior margin area receiv oper characterist auroc endogen bhb level analyz laboratori point care devic predict mgs analyz scan complet kd result mean age women nonwhit median achiev bhb level mmoll th th percentil ke drink th th percentil th th percentil h kd th th percentil h kd primari outcom achiev ke drink h kd h kd particip noninferior p ke vs h h kd endogen bhb level robust predict mgs auroc ci bhb correct classifi scan point care devic provid compar predict valu conclus healthi volunt ke inferior kd achiev mgs serum bhb high predict biomark mgs clinic implement upstream f fdg pet rapid facilit point care test reduc fals posit scan | D007659;D007662 | T033;T047;T109;T046 |
34,675,106 | ggc repeat expans notchnlc taiwanes patient inherit neuropathi ggc repeat expans untransl region notchnlc recent identifi caus neuron intranuclear inclus diseas niid may manifest peripher neuropathi aim studi investig contribut inherit neuropathi | D036341;D009419;D019636;D010523 | T116;T047;T123 |
34,675,105 | proteom discoveri noninvas biomark associ sport relat concuss sport relat concuss affect million individu across unit state year current techniqu diagnos monitor reli larg subject measur goal discov valid object quantifi noninvas biomark potenti use sport relat concuss diagnosi | D001265;D001924;D013177 | T056;T037 |
34,675,104 | evalu efficaci onlin learn tool eeg teach prospect cohort studi determin effect month interact multimod web base eeg teach program eeg onlin improv eeg analysi interpret skill neurologist neurolog resid technologist particular resourc limit set | D020375 | T065 |
34,675,101 | n trial neurolog systemat review perform systemat review publish n trial eg singl patient crossov trial neurolog disord includ assess methodolog qualiti report | D057189;D009462 | T091;T170 |
34,675,100 | effect levetiracetam use durat overal surviv isocitr dehydrogenas wild type glioblastoma adult observ studi associ levetiracetam surviv isocitr dehydrogenas idh wild type glioblastoma controversi investig whether durat levetiracetam use standard chemoradi protocol affect overal surviv os patient idh wild type glioblastoma | D001932;D005909;D007521;D000077287 | T191;T116;T121;T109;T126 |
34,675,097 | bilater structur network abnorm epilepsi associ bottom sulcus dysplasia identifi white matter fiber tract exhibit structur abnorm patient bottom sulcus dysplasia bosd investig associ seizur activ | D004827;D066127 | T033;T023;T047;T024 |
34,675,094 | natur histori facioscapulohumer dystrophi children year follow data natur histori facioscapulohumer dystrophi fshd childhood limit critic improv patient care clinic trial readi object describ diseas cours fshd children | D020391;D064171 | T023;T047 |
34,675,085 | flush offens term vancomycin infus reaction electron medic record medic establish continu complicit degrad nativ peopl unit state use racist phrase red man syndrom rms describ histamin releas syndrom accompani vancomycin infus | D004501;D014640 | T065;T116;T195 |
34,675,084 | novel redirect cell immunotherapi advanc prostat cancer immunotherapi fail achiev durabl remiss advanc prostat cancer patient potent cell redirect strategi may need overcom immunolog exclus suppress tumor microenviron clinic trial underway seek defin optim target cell redirect psma psca steap well optim strategi car bispecif antibodi result continu emerg trial understand differenti toxic efficaci therapi base target function modif key advanc promis therapi toward clinic practic review provid uniqu depth breadth perspect regard divers immunotherapi strategi current clinic investig men advanc prostat cancer | D018033;D011471 | T129;T191;T121;T116 |
34,675,082 | grapevin drought express esca leaf symptom context climat chang plant mortal increas worldwid natur agroecosystem howev understand under caus limit complex interact abiot biotic factor technic challeng limit investig interact studi interact two main driver mortal drought vascular diseas esca one world econom valuabl fruit crop grapevin found drought total inhibit esca leaf symptom express disentangl plant physiolog respons two stress quantifi whole plant water relat ie water potenti stomat conduct carbon balanc ie co assimil chlorophyl nonstructur carbohydr result highlight distinct physiolog behind two stress respons indic esca subsequ stomat conduct declin result decreas water potenti generat differ gas exchang nonstructur carbohydr season dynam compar drought | D055864;D013312 | T121;T039;T046;T032;T040;T070 |
34,675,080 | soil chemistri determin whether defens plant secondari metabolit promot suppress herbivor growth plant secondari special metabolit mediat import interact rhizospher phyllospher compartment function interact determin plant environ interact well understood investig dual role maiz benzoxazinoid leaf defens root siderophor shape interact maiz major global insect pest fall armyworm find benzoxazinoid suppress fall armyworm growth plant grown soil low avail iron enhanc growth soil higher avail iron manipul experi confirm benzoxazinoid suppress herbivor growth iron defici condit presenc chelat iron enhanc herbivor growth presenc free iron growth medium revers protect effect benzoxazinoid associ major chang plant primari metabol plant defens activ modul interplay soil iron benzoxazinoid explain fall armyworm perform instead increas iron suppli fall armyworm benzoxazinoid presenc free iron enhanc larval perform work identifi soil chemistri decis factor impact plant secondari metabolit herbivor growth also demonstr multifunct plant secondari metabolit drive interact abiot biotic factor potenti consequ plant resist variabl environ | D060434 | T040;T008 |
34,675,079 | acut csk inhibit hinder b cell activ constrain pi kinas pathway cell antigen receptor tcr b cell antigen receptor bcr signal initi tight regul src famili kinas sfks sfks posit regul tcr signal nave cell posit negat regulatori role bcr signal nave b cell proper regul activ depend oppos action receptor tyrosin phosphatas cd cd cytoplasm tyrosin kinas c termin src kinas csk csk major negat regul sfks use pp analog sensit csk csk system previous shown inhibit csk increas sfk activ lead augment respons weak tcr stimuli cell howev effect csk inhibit b cell known studi surpris found inhibit csk led mark inhibit bcr stimul cytoplasm free calcium increas erk activ despit increas sfk activ b cell contrast effect observ cell investig reveal acut csk inhibit suppress bcr mediat phosphatidylinositol trisphosph pip product b cell restor pip level b cell cd cross link ship defici elimin negat regulatori effect csk inhibit reveal critic role csk maintain appropri level sfk activ regul pip amount mean compens sfk fluctuat prevent inappropri b cell activ regulatori mechan control pip amount may also contribut b cell anergi self toler | D008213 | T043 |
34,675,078 | orbitofront cortex dorsal striatum function connect predict incub opioid crave voluntari abstin recent introduc rat model incub opioid crave voluntari abstin induc negat consequ drug seek use rest state function mri determin whether longitudin function connect chang orbitofront cortex ofc circuit predict incub opioid crave voluntari abstin train rat self administ either intraven oxycodon palat food introduc electr barrier caus cessat reward self administr test rat oxycodon food seek extinct condit immedi self administr train earli abstin electr barrier exposur late abstin imag brain self administr earli late abstin analyz chang ofc function connect induc reward self administr electr barrier induc abstin oxycodon seek greater late earli abstin incub oxycodon crave oxycodon self administr experi increas ofc function connect dorsal striatum relat circuit posit correl incub oxycodon seek contrast electr barrier induc abstin decreas ofc function connect dorsal striatum relat circuit negat correl incub oxycodon seek food seek greater earli late abstin abat food crave food self administr experi electr barrier induc abstin decreas maintain function connect circuit correl abat food seek oppos function connect chang ofc dorsal striatum relat circuit induc opioid self administr versus voluntari abstin predict individu differ incub opioid crave | D009042 | T080;T041;T078 |
34,675,075 | explor deep neural network via layer peel model minor collaps imbalanc train paper introduc layer peel model nonconvex yet analyt tractabl optim program quest better understand deep neural network train suffici long time name suggest model deriv isol topmost layer remaind neural network follow impos certain constraint separ two part network demonstr layer peel model albeit simpl inherit mani characterist well train neural network therebi offer effect tool explain predict common empir pattern deep learn train first work class balanc dataset prove solut model form simplex equiangular tight frame part explain recent discov phenomenon neural collaps v papyan x han l donoho proc natl acad sci usa import move imbalanc case analysi layer peel model reveal hitherto unknown phenomenon term minor collaps fundament limit perform deep learn model minor class addit use layer peel model gain insight mitig minor collaps interest phenomenon first predict layer peel model confirm comput experi | D000077321;D016571 | T170;T066 |
34,675,070 | embryon ltr retrotransposon suppli promot modul somat tissu long termin repeat ltr retrotransposon wide distribut across human genom accumul retrovir integr germlin dna latent genet modul activ ltr promot observ germlin cell howev littl known mechan under activ transcript somat tissu integr previous transcriptom data set public avail data set show ltr famili mlta mlta primarili express human four cell eight cell embryo also activ adult somat tissu particular pineal gland three mlta element function promot first exon protein code gene abc cola galnt specif pineal gland human macaqu suggest exapt ltrs promot occur recent primat evolut analysi provid insight possibl transit germlin insert somat express ltr retrotransposon | D018626;D020079 | T114;T123 |
34,675,069 | share evolutionari trajectori three independ neo sex chromosom drosophila dosag compens dc x chromosom counteract deleteri effect gene loss chromosom howev dc effici x chromosom also degener inde occur drosophila miranda neo neo x acceler pseudogen examin general pattern investig evolut two addit neo sex chromosom emerg independ albomican americana reanalyz neo sex chromosom evolut miranda compar genom transcriptom analys reveal pseudogen rate neo x also acceler albomican americana although lesser extent miranda male neo x link gene whose neo link homolog pseudogen tend regul whose neo link homolog remain function moreov gene strong function constraint gene high express testi tend remain function neo x neo respect focus miranda albomican neo sex chromosom emerg independ autosom found gene tend becom pseudogen parallel neo gene includ idgf jhi may unnecessari even harm male result indic neo sex chromosom drosophila share common evolutionari trajectori emerg may prevent sex chromosom evolutionari dead end | D004330;D012730 | T026;T204 |
34,675,066 | risk liver cirrhosi hbvhcv infect individu first degre relat liver cancer develop valid simpl model identif high risk popul among hepat b virus hbv hepat c virus hcv infect individu first degre relat fdr liver cancer import implement precis intervent cross section studi conduct framework popul base cancer screen program urban china canspuc aim develop valid simpl noninvas model could assess stratifi cirrhosi risk hbvhcv infect individu fdrs liver cancer peopl particip liver cancer screen henan provinc enrol use data set consist particip admit octob decemb point scale risk score model develop logist regress base educ background dietari habit smoke index cook oil fume exposur histori sever trauma hbvhcv infect status histori diabet histori hyperlipidemia parent histori liver cancer model show excel discrimin area receiv oper characterist curv auroc confid interv ci fair calibr hosmer lemeshow test p preval rate medium high risk group ci ci time low risk group respect intern valid bias correct auroc ci extern valid data set consist particip admit januari octob model achiev similar discrimin calibr risk stratif abil conclus risk score model develop practic tool screen prevent liver cirrhosi among hbvhcv infect individu fdrs liver cancer prevent relev creat simpl noninvas cirrhosi risk model individu infect hbvhcv fdrs liver cancer model use prognosi hbvhcv infect also prevent hepatocellular carcinoma | D006528;D006509;D006526;D008113 | T191;T047 |
34,675,065 | urgent need expand cancer screen octob privileg testifi hous energi commerc committe subcommitte health hear enhanc public health legisl protect children famili commentari base written testimoni provid subcommitte issu relat cancer screen earli detect highlight research progress updat guidelin new challeng field emphas import screen asymptomat risk popul detect precancer lesion cancer earli stage | D055088;D009369 | T058;T191;T060 |
34,675,064 | dietari pterostilben mta target intercept high risk premalign prostat cancer prostat cancer remain one preval cancer age men activ surveil subpopul patient prostat cancer includ men vari cancer risk categori precancer diseas due prostat intraepitheli neoplasia pin heterogen identifi molecular alter associ pin provid prevent measur find novel pharmacolog target cancer intercept target nutrit intercept may prove appropri chemoprevent intermedi high risk activ surveil patient generat two prostat specif transgen mous model one overexpress mta rmta overexpress mta background pten heterozygos rmta ptenf examin potenti chemoprevent efficaci dietari pterostilben show mta promot neoplast transform prostat epitheli cell activ cell prolifer surviv lead pin develop moreov mta cooper pten defici acceler pin develop increas cell prolifer mta associ signal show mice fed pterostilben supplement diet exhibit favor histopatholog decreas sever number pin foci accompani reduc prolifer angiogenesi inflamm concomit reduct mta mta associ cyclind notch oncogen mir mir level prevent relev develop novel intercept strategi prostat cancer chemoprevent paramount goal clinic oncolog offer preclin evid potenti pterostilben promis natur agent mta target intercept strategi futur cancer prevent trial toward protect select patient prostat cancer activ surveil develop cancer | D011230;D019048;D011471 | T191 |
34,675,063 | impact sar cov pandem access contracept pregnanc intent nation prospect cohort studi uk popul evalu impact covid pandem access contracept pregnanc intent | D000086382;D000086402 | T047;T005;T067 |
34,675,062 | neural stemprecursor cell dynam chang epigenet landscap differenti respond bmp signal fate switch brain develop neocort develop tight regul neurogenesi astrogenesi switch neural precursor cell npcs critic generat balanc number neural cell type proper brain function accumul evid indic complex array epigenet modif avail extracellular factor control time neuron astrocyt differenti howev understand npc fate regul still far complet bone morphogenet protein bmps renown cytokin induc astrogenesi gliogen late gestat npcs also promot neurogenesi mid gestat npcs although under mechan remain elus perform multipl genom wide analys demonstr smad transcript factor act downstream bmp signal target dramat differ genom region neurogen gliogen npcs found histon hk trimethyl dna methyl around smad bind site chang rapid gestat proceed strong associ alter access smad target bind site furthermor identifi two lineag specif smad interact partner sox neurogen sox astrocyt differenti ensur smad regul fate specif gene induct find illumin exquisit regul npc properti chang mediat interplay cell extrins cue intrins epigenet program cortic develop | D058953 | T025 |
34,675,061 | effici hemogen endotheli cell specif runx depend baselin chromatin access runx regul tgf target gene hematopoiet stem progenitor cell hspcs generat de novo embryo hemogen endotheli cell hec via endotheli hematopoiet transit eht requir transcript factor runx ectop express runx alon effici promot eht hspc format embryon endotheli cell ec less effici fetal adult ec effici correl baselin access tgf relat gene associ endotheli mesenchym transit endomt particip ap smad initi chromatin remodel along runx site activ tgf signal improv effici runx specifi fetal ec hec thus abil runx promot eht depend abil recruit tgf signal effector ap smad turn determin chang chromatin landscap embryon versus fetal ec work provid insight regul endomt eht guid reprogram effort clinic applic | D055018 | T025 |
34,675,060 | target may overtak chemo immunotherapi nsclc result phase ii trial two target agent antibodi drug conjug trastuzumab deruxtecan target tyrosin kinas inhibitor poziotinib indic promis efficaci could lead new standard care mutant non small cell lung cancer | D002289;D008175 | T191 |
34,675,059 | intermedi renal outcom kidney failur mortal obes kidney donor obes associ two archetyp kidney diseas risk factor hypertens diabet concern effect diabet hypertens obes kidney donor might magnifi remain kidney led exclus mani obes candid kidney donat | D019520 | T098 |
34,675,058 | impact diabet product india diabet increas risk prematur mortal consider impact work product sought examin impact diabet india term excess prematur mortal year life lost yll product adjust life year pali lost associ econom impact | D017281;D003920 | T080;T047 |
34,675,057 | trend diabet relat hospit admiss transit period adolesc adulthood state california studi examin incid diabet relat hospit admiss describ characterist among youth emerg adult type td type diabet td california | D003922;D003924;D016883 | T047 |
34,675,054 | prediabet defin first measur hba c predict higher cardiovascular risk compar hba c diabet rang cohort studi nationwid registri assess risk major advers cardiovascular event mace caus mortal initi medic treatment subject prediabet accord first time measur hba c | D002318;D003924;D011236 | T047 |
34,675,053 | telephon triag young adult chest pain popul analysi nhs call scottish unschedul care telephon triag increas use manag unschedul care demand younger adult frequent user common call chest pain compar pathway care younger adult call chest pain associ patient characterist telephon triag recommend hospit admiss | D013689;D014218 | T061;T057;T073 |
34,675,050 | biomark signatur progress idiopath pulmonari fibrosi idiopath pulmonari fibrosi ipf progress lung diseas circulatori biomark potenti guid manag clinic practic assess prognost role serum biomark three independ ipf cohort australian idiopath pulmonari fibrosi registri aipfr trent lung fibrosi tlf prospect observ fibrosi lung clinic endpoint profil | D054990 | T047 |
34,675,042 | optim treatment goal long term health outcom among patient type diabet mellitus consider confus treatment target result recent chang guidelin evid medic guidelin came clinic trial high select patient wherea treatment goal may differ subgroup studi aim assess optim treatment goal ac blood pressur low densiti lipoprotein cholesterol ldl c patient type diabet mellitus tdm lead optim health outcom differ treatment strategi | D003924 | T047 |
34,675,036 | prompt wale project nation scale evid base intervent improv safeti train matern healthcar increas recognit import develop test strategi scale effect intervent nhs long term plan acknowledg often gold standard approach problem alreadi exist somewher within nhs howev replic wide across system | D003695;D019317 | T058;T091;T093 |
34,675,033 | clinic outcom covid cirrhosi systemat review meta analysi observ studi covid continu pose signific healthcar challeng throughout world comorbid includ diabet hypertens associ signific higher mortal risk howev effect cirrhosi covid outcom yet systemat assess | D000086382;D006973 | T047;T067 |
34,675,026 | access fludrocortison hydrocortison children congenit adren hyperplasia eastern mediterranean region take villag congenit adren hyperplasia cah untreat carri high morbid mortal higher incid cah expect countri consanguin common countri eastern mediterranean region emro cah manag lifelong treatment fludrocortison hydrocortison analysi perform emro countri territori plus algeria review countri offer neonat screen programm cah describ barrier opportun access oral fludrocortison oral inject hydrocortison neonat cah screen avail nation qatar kuwait partial lebanon saudi arabia review nation list essenti medicin neml found countri includ fludrocortison includ oral hydrocortison fludrocortison includ low incom countri oral hydrocortison includ one low incom countri contact paediatr endocrinologist countri assess perceiv avail medicin overal relat good consist inclus fludrocortison hydrocortison neml actual avail countri propos sever mechan improv access includ prequalif common registr process group countri pool procur work local pharmaceut compani special access status medicin yet regist countri compound suggest access medicin requir collabor health profession famili patient health author pharmaceut compani | D000312;D005438 | T047;T121;T109;T125 |
34,675,023 | explor concept compass care home set scope review protocol widespread agreement medic care without compass patient centr patient still routin cite feel lack compass care environ dearth research compass experienc non hospit set care home resid staff key stakehold scope review aim determin bodi exist publish research explicit refer compass empathi context care home | D004645;D012107 | T055;T170;T169;T062;T054;T081;T096 |
34,675,022 | transcov cohort protocol epidemiolog studi assess impact critic ill covid patient long distanc transfer intens care unit spring four region franc face surg sever covid patient threaten overflow local intens care unit icu capac emerg respons march april estim patient transfer overcrowd icus eight french region four neighbour countri intens geograph spread divers vector use unpreced studi aim assess impact inter icu transfer short term medium term physic psycholog outcom popul sever covid patient | D000086382;D016638 | T047;T067 |
34,675,021 | elimin hepat c balear island spain protocol intervent studi test link peopl use drug treatment care hepat c virus hcv high infecti dead diseas affect million peopl worldwid million peopl live balear island spain individu untreat hcv estim peopl use drug pwud one key risk group hcv infect global carri micro elimin approach focus popul crucial achiev goal elimin hcv thus primari object studi valid model care simplifi screen linkag hcv care pathway pwud balear island | D006526;D004364;D015819 | T048;T047;T121 |
34,675,020 | gastric venous reconstruct reduc gastric venous congest total pancreatectomi studi protocol singl centr prospect non randomis observ studi ideal phase gender studi gastric v en ous rainag e r econstruct total pancreatoduodenectomi tp standard surgic approach treat extend pancrea tumour tp perform splenectomi left gastric vein lgv sometim need sacrif oncolog technic reason result gastric venous congest gvc gvc lead gastric venous infarct turn caus gastric perfor abdomin sepsi avoid gastric venous infarct partial total gastrectomi usual perform gvc occur tp howev gastrectomi avoid reconstruct gastric venous outflow overcom gvc avoid gastric venous infarct current studi aim assess role gastric venous outflow reconstruct prevent gvc tp avoid gastrectomi | D006940;D010180 | T047;T061;T046 |
34,675,019 | experi awar research integr among japanes physician nationwid cross section studi explor awar practic clinic research integr among japanes physician | D035843;D010820 | T097;T062 |
34,675,018 | video game therapi mobil dual task multipl sclerosi studi protocol randomis control trial multipl sclerosi ms one major caus disabl young adult affect mobil compromis daili live activ particip social life cognit domain also frequent impair peopl ms pwms particular capac perform dual task activ impair cognit process abil need treat motor cognit aspect need consid togeth recent video game therapi vgt use rehabilit improv motor outcom cognit process speed aim studi test efficaci commerci avail vgt mobil dual task pwms compar standardis balanc platform train bpt | D009103;D018910 | T047;T073 |
34,675,017 | seropreval associ factor matern cytomegalovirus southern ethiopia cross section studi aim studi assess seropreval associ factor cytomegalovirus cmv among pregnant women southern ethiopia | D003587;D011251 | T047;T005 |
34,675,016 | differenti impact physic distanc strategi social contact relev spread sar cov evid cross nation onlin survey march april investig chang social contact pattern follow gradual introduct non pharmaceut intervent implic infect transmiss earli phase pandem | D000086382;D000086402 | T047;T005;T067 |
34,675,015 | incid stroke transient ischaem attack determin poststrok mortal among immigr denmark popul base cohort studi use recent registri data aim quantifi incid stroke transient ischaem attack tia examin factor influenc risk poststrok mortal among immigr compar danish born individu | D002545;D054242;D002546;D020521 | T047;T098;T046 |
34,675,014 | impact incom eat speed new onset diabet among men retrospect cohort studi examin impact incom eat speed new onset diabet among men | D003920 | T047 |
34,675,013 | doctor seek peer support qualit interview studi understand doctor reflect seek help organis peer support servic | D010820 | T097 |
34,675,012 | valu earli critic care transthorac echocardiographi patient undergo mechan ventil retrospect studi evalu whether earli intens care transthorac echocardiographi tte improv prognosi patient mechan ventil mv | D007362;D012121 | T061;T093;T073 |
34,675,011 | associ healthi lifestyl score chang qualiti life health relat qualiti life longitudin analysi south korean panel data aim determin influenc chang aggreg score healthi lifestyl factor health relat qualiti life hrqol overal qualiti life qol korean older adult popul | D000375;D011788 | T040;T033;T078 |
34,675,010 | preval outcom twin pregnanc botswana nation birth outcom surveil studi studi aim evalu preval outcom twin pregnanc botswana | D059285;D047928 | T033;T046 |
34,675,009 | patient report outcom measur follow revis knee replac review prom instrument utilis measur properti use cosmin checklist identifi patient report outcom measur prom use evalu symptom health status qualiti life follow discretionari revis revis knee joint replac valid joint specif prom measur properti qualiti evid | D019645;D057189 | T170;T061 |
34,675,008 | determin adolesc percept access healthcar servic kingdom saudi arabia jeeluna nation survey find studi aim identifi determin adolesc access healthcar servic | D006296;D006297 | T058;T033;T080 |
34,675,001 | european glaucoma societi terminolog guidelin glaucoma th edit time everi uniqu respons person ask act well answer differ everi person everi situat uniqu everi person differ everi person sure must algorithm assist us come right answer unfortun right answer answer appropri conclud moment situat written guidelin appli appropri everi uniqu situationunfortun physician suckl fallaci good goos good gander phrase medic term normal find good abnorm find bad simpl often wronggood clinician know care must person optim call normal find give rough guidanc sometim applic group frequent wrong individu consid intraocular pressur iop normal iop mmhg good bad other abnorm iop mmhg good bad other bombard myth sanctiti standard distribut curv hard think independ specif also unfortun doctor prone decid patient often basi normat data relev import particular patient surpris want help default seem easi safe non think way hold account outcomesomebodi decid els would live anarch world also true none us know much need know act appropri seek advic call expert us care peopl well essenti consid other recommend look expert howev expert sometim right sometim wrong rememb von graef recommend surgic iridectomi glaucoma elliot recommend mustard plaster shoulder glaucoma becker base treatment tonograph find weve report success penetr cyclodiathermi glaucoma lichter advis laser trabeculoplasti mani thought cypass great investig advanc glaucoma intervent studi indic iop usual around mmhg better one usual around mmhg wrong author guidelin done excel provid general framework ophthalmologist hang piec evid abl evalu valid import evid meticul provid valuabl servic ophthalmologist none individu either time skill fulli inform practic author consid whether valid inform relev particular person consid process consid relev essenti alway relev base particular uniqu patient uniqu doctor uniqu situat guidelin author provid regard remind us consid relev patient situat patient perspect even import servic ophthalmologist benefit patient result thought use guidelinesw need also rememb diagnos generic within everi diagnosi differ exampl diagnosi primari open angl mean affect rapid go blind despit thought treatment other keep sight even without treatment diagnosi chandler syndrom mean surgeri work well other poor one never direct diagnosi treatment condit rather person object well personth previous european glaucoma societi guidelin use intern good eg provid updat use informationth guidelin practic inspir contribut georg l spaeth ba md esposito research professor will eye hospitalsidney kimmel medic collegethoma jefferson univers wwweugsorg guidelin writer author contributorsaugusto azuara blanco editor luca bagnascoalessandro bagnisjoao barbosa bredachiara bonzanoandrei brezhnevalain broncarlo cutolobarbara cvenkelstefano gandolfit garway heathilmira gazizovagus gazzardfranz grehnand heijlcornelia hirngbor hollanton hommermichel iesteringrida janulevicienegauti jhannessonmiriam kolkotianj lijo martnez de la casafr meier gibbonsmaria musolinomarta pazosnorbert pfeiffersergey petrovlui abegao pintoriccardo scottoingeborg stalmansgordana sunaricmgevandernst tammjohn thygesenfoti topouzismarc tteberg harmscarlo e traverso editor anja tuulonenzoya veselovskayaananth viswanathanilgaz yalvacthierri zeyenguidelin committeeaugusto azuara blanco chair carlo e traverso co chair manuel michelessi ngp co chair lui abegao pintomichel iesterjoao bredacarlo cutolopanayiota fountigerhard garhoeferandrea katsanosmiriam kolkofrancesco oddonemarta pazosverena prokosch willingcedr schweitzerandrew tathammarc toteberg harmsacknowledgementsanja tuulon garway heathrichard wormaldtianj limanuel michelessijenni burrazuara blanco methodolog oversighttianj li riaz qureshi us cochran eye vision group manuel michelessi eg lead evid reviewmanuel michelessigianni virgilijoao barbosa bredacarlo cutolomarta pazosandrea katsanosgerhard garhofermiriam kolkoverena prokoschpanayota fountifrancesco oddoneali ahm al rajhitianj liriaz qureshi azuara blanco contribut evid reviewkaren osborn joanna bradley glaucoma uk chariti contribut section matter patient https glaucomauk addit contribut made follow peopl specif topicseleftherio anastasopoulospanayiota fountigus gazzardfranz grehnand heijlgbor hollfoti topouzisanja tuulonenananth viswanathamth team clinica oculistica univers genoa medic edit illustrationsluca bagnascoalessandro bagnischiara bonzanocarlo cutolomichel lestermaria musolinoroberta parodiriccardo scottow would like thank follow colleagu help reviewingedit section landmark randomis control trial glaucomajo capriolit garway heath gus gazzard divakar gupta ander heijl michael kass stefano miglior david musch norbert pfeiffer thierri zeyenextern reviewsw would like thank follow societi expert world glaucoma associ parul ichhpujanimonisha nongpiurtanuj dadasola olawoyejaym viannamin hee suhfarouk garbasimon skalickyalex huangfarouk garbapradeep ramuluverena prokoschcarolina gracitelli american glaucoma societi josh stein latin american glaucoma societi daniel grigeraw would like thank extern review whose comment list https wwweugsorgengguidelinesasp eg execut committeet garway heath presid foti topouzi vice presid ingeborg stalman treasur anja tuulonen past presid lui abegao pintoandrei brezhnevalain brongauti jhannessonnorbert pfeifferth board european glaucoma societi foundationcarlo e traverso chair foti topouzi vice chair franz grehnand heijljohn thygesenthierri zeyen glossari fu fluorouracil aac acut angl closur acg angl closur glaucoma agi advanc glaucoma intervent studi ah aqueous humour ai artifici intellig alt argon laser trabeculoplasti bac benzalkalonium chlorid cct central corneal thick cdr cup disc ratio cigt initi glaucoma treatment studi cntgs collabor normal tension glaucoma studi dct dynam contour tonometri eagl effect earli len extract treatment primari angl closur glaucoma egp european glaucoma prevent studi eg european glaucoma societi ema european medicin agenc emgt earli manifest glaucoma trial fc flow chart fdt frequenc doubl technolog fc fix combin fl fixat loss fn fals negat fp fals posit gat goldmann applan tonometri ght glaucoma hemifield test grade grade recommend assess develop evalu hrt heidelberg retina tomographi ice irido corneal endotheli syndrom iol intraocular len iop intraocular pressur itc iridotrabecular contact iv intraven light laser glaucoma ocular hypertens trial lpi laser peripher iridotomi lv loss varianc md mean defect mean deviat mmc mitomycin c nct non contact tonometri nd yag neodymium dope yttrium aluminum garnet ntg normal tension glaucoma oag open angl glaucoma oct optic coher tomographi oht ocular hypertens oht ocular hypertens treatment studi onh optic nerv head ora ocular respons analys osd ocular surfac diseas pac primari angl closur pacg primari angl closur glaucoma pac primari angl closur suspect pas peripher anterior synechia pcg primari congenit glaucoma pds pigment dispers syndrom pga prostaglandin analogu poag primari open angl glaucoma pg pigmentari glaucoma psd pattern standard deviat pxf pseudoexfoli syndrom pxfg pseudoexfoli glaucoma rct randomis control trial rnfl retin nerv fiber layer rop rate progress sap standard autom perimetri sita swedish interact threshold algorithm slt select laser trabeculoplasti swap short wavelength autom perimetri tlpi thermal laser peripher iridoplasti tm trabecular meshwork ubm ultrasound biomicroscopi ugh uveiti glaucoma hyphema syndrom ukgt unit kingdom glaucoma treatment studi vegf vascular endotheli growth factor vf visual file vfi visual field index zap zhongshan angl closur prevent trial | D005901;D015812;D005902;D017408;D009626 | T047;T170 |
34,674,999 | uniform descript periop brain mri find infant sever congenit heart diseas result european collabor uniform descript brain mr imag find infant sever congenit heart diseas assess risk factor predict outcom compar center lack object uniform describ spectrum periop brain mr imag find infant congenit heart diseas | D006330;D014188 | T019 |
34,674,998 | anatom neuroimag characterist posterior fossa type ependymoma subgroup posterior fossa type pfa ependymoma molecular subgroup pfa pfa subtyp gene express profil suggest pfa pfa tumor distinct development origin differ rostrocaud level brainstem therefor test hypothesi pfa pfa ependymoma differ anatom mr imag characterist present | D004806;D015192 | T191 |
34,674,997 | chang ventricular cortic volum follow shunt placement patient idiopath normal pressur hydrocephalus chang ventricular extraventricular csf space studi follow shunt placement patient idiopath normal pressur hydrocephalus region chang cortic volum chang import better inform diseas pathophysiolog evalu copatholog purpos work investig chang ventricular cortic volum patient idiopath normal pressur hydrocephalus follow ventriculoperiton shunt placement | D006849;D006850 | T033;T047;T019 |
34,674,996 | endovascular manag intracrani dural avf principl intracrani dural avf abnorm communic arteri suppli dura mater drain cortic vein venous sinus believ form respons venous insult thrombosi trauma infect classif manag depend presenc drainagereflux cortic vein drainag mark elev risk hemorrhag venous congest result neurolog deficit avf toler symptom benign drainag pattern manag conserv intoler symptom present hemorrhageneurolog deficit aggress drainag pattern indic intervent treatment option includ microsurg disconnect endovascular transarteri embol transven embol combin first seri articl endovascular manag intracrani dural avf outlin principl outcom endovascular treatment | D020785;D004621;D057510 | T190;T047;T019;T061 |
34,674,995 | safeti oral py inhibitor intervent neuroradiolog current status perspect field intervent neuroradiolog antiplatelet agent common use prepar patient implant perman endovascular materi among avail drug clopidogrel frequent use one resist phenomena consid relat common prasugrel ticagrelor recent ad pharmacolog arsenal safeti agent patient undergo neurointervent procedur still subject discuss cumul experi drug less extens clopidogrel experi patient neurolog field less extens cardiolog domain present articl provid narrat review studi investig safeti issu oral py inhibitor intervent neuroradiolog discuss potenti rout futur research | D010975;D058921 | T121 |
34,674,994 | spiral weight tse brain mr imag initi clinic experi spiral mr imag may enabl improv imag qualiti higher scan speed cartesian trajectori sought compar novel spiral weight tse sequenc convent cartesian artifact robust non cartesian sequenc name multivan routin clinic brain mr imag | D008279;D066127 | T023;T170;T060;T024;T059 |
34,674,992 | haemoglobin red blood cell refer interv infanc need updat haematolog refer data infanc studi aim defin interv haemoglobin red blood cell biomark base data larg cohort longitudin follow swedish infant | D000740;D006454 | T116;T047;T123 |
34,674,988 | incid characterist fall hospit patient cohort studi estim incid fall know characterist term locat tempor injuri produc analys sociodemograph clinic characterist patient suffer fall | D007297 | T101 |
34,674,986 | result year kidney pancrea transplant type diabet patient comunidad valenciana simultan pancrea kidney spk transplant proven option treatment patient type diabet mellitus relat end stage renal diseas candid kidney transplant result begin spk transplant program comunidad valenciana present | D003922;D016030;D016035 | T047;T061 |
34,674,985 | real life effect control risk factor associ initi cardiovascular polypil creat equipot drug work aim analyz impact spain nation center cardiovascular research cnic ferrer cardiovascular cv polypil blood pressur bp low densiti lipoprotein cholesterol cldl level patient healthcar area previous took equipot dose statin antihypertens | D002318;D019161 | T047;T121;T109 |
34,674,984 | bing neel syndrom updat diagnosi treatment bing neel syndrom bns rare syndrom occur patient waldenstrom macroglobulinemia character lymphoplasmacyt infiltr leptomening tissu andor central nervous system repres extramedullari manifest may translat various neurolog symptom accur diagnosi bns establish via histolog sampl cerebrospin fluid examin molecular analysi genet marker includ immunoglobulin heavi locus rearrang myd lp mutat use bruton tyrosin kinas inhibitor ibrutinib result promis outcom review discuss pathophysiolog clinic manifest diagnost characterist overview current treatment modal bns | D001927;D008258 | T191;T047 |
34,674,983 | inject hypomethyl agent manag myelodysplast syndrom patient perspect treatment recent patient mdss could receiv hmas via intraven iv subcutan sc administr oral hma recent approv altern ivsc administr studi assess impact ivsc hma mds patient experi challeng view oral mds treatment | D000964;D009190 | T191;T046;T121 |
34,674,982 | prognost core bind factor cbf acut myeloid leukemia complex karyotyp core bind factor acut myeloid leukemia cbf aml recurr genet abnorm inv pq p q cbfb myh usual prognost favor heterogen group addit abnorm chang prognosi | D050660;D015470 | T116;T191;T123 |
34,674,981 | improv health relat qualiti life symptom patient previous untreat chronic lymphocyt leukemia final result phase ii gibb studi combin obinutuzumab bendamustin evalu health relat qualiti life hrqol patient chronic lymphocyt leukemia cll receiv first line chemoimmunotherapi gibb singl arm phase ii studi obinutuzumab plus bendamustin bg | D015451;D011788 | T191;T078 |
34,674,980 | academ impact advanc clinic fellowship train among general thorac surgeon advanc clinic fellowship train becom popular option surgic traine seek bolster clinic train expertis howev long term academ impact addit train follow tradit thorac surgeri fellowship unknown studi aim delin impact advanc clinic fellowship subsequ research product advanc academ career among general thorac surgeon | D035843;D007396;D066231;D013903 | T097;T065;T062;T091 |
34,674,979 | draw visual communic medicin novel pilot cours senior medic student visual aid draw report improv patient comprehens retent adher sought determin feasibl teach live draw clinic communic medic student | D004504;D008511;D013337 | T091;T065;T097 |
34,674,976 | surgic manag hidraden suppurativa unit kingdom nation survey care pathway inform theseus studi evid base underpin treatment efficaci effect hidraden suppurativa hs limit highlight wide rang research prioriti establish jame lind allianc prioriti set partnership psp understand landscap surgic practic key step toward tackl undesir variat care resolv treatment uncertainti survey current surgic practic aim describ care pathway involv surgeon manag hs surgic approach manag | D017497 | T047 |
34,674,972 | organoid model assess lung cell fate decis diseas respons organoid deriv various cell type lung provid reproduc tractabl model understand complex signal drive cell fate decis regen context review provid retrospect account organoid methodolog outlin new opportun optim method explor emerg concept lung biolog moreov examin benefit integr organoid assay vivo model explor various nich compart respiratori system respond acut chronic lung diseas strateg implement improv organoid techniqu provid excit new opportun understand identifi new therapeut approach amelior lung diseas state | D008168;D009940 | T023;T024 |
34,674,969 | self report drive difficulti patient bilater cataract presenc cataract caus reduct visual acuiti va contrast sensit cs thus affect individu daili activ aim studi investig self report drive difficulti patient bilater cataract | D001334;D002386 | T190;T033;T047;T056 |
34,674,968 | converg insuffici symptom survey ciss score predict sever number clinic sign converg insuffici young adult african studi aim investig correl converg insuffici symptom survey ciss score sign converg insuffici ci evalu sensit specif ciss predict ci ametropia among young adult univers student | D015835;D012030 | T033;T047;T184 |
34,674,967 | visual satisfact result implant trifoc panoptix intraocular len cataract surgeri assess visual result includ lapid kushlin defocus coeffici satisfact follow implant panoptix trifoc intraocular len | D002386;D007910 | T190;T033;T074;T047 |
34,674,966 | effect safeti motion style acupunctur treatment pelvic joint herniat lumbar disc radiat pain prospect observ pilot studi conserv treatment effect treat manag herniat lumbar disc radiat leg pain | D015670;D007405;D017116 | T047;T184;T061 |
34,674,965 | ensur buprenorphin access rural communiti pharmaci prevent overdos opioid relat drug overdos rapid increas unit state especi rural southern appalachian region use buprenorphin contain medic treat opioid use disord oud evid base approach proven reduc overdos death risk access treatment uneven less access part unit state overdos rate higher pharmaci dispens buprenorphin key compon access yet barrier relat perceiv actual regulatori constraint train gap stigma challeng prescrib pharmacist communic limit dispens life save medic | D002047;D062787;D009293;D010594 | T121;T109;T073;T048;T093;T037;T058 |
34,674,963 | human attract cue mosquito host seek behavior femal mosquito use chemic physic cue includ vision smell heat humid orient toward host bodi odor produc skin resid bacteria convert metabolit secret sweat odor confer characterist bodi scent mosquito detect compound use olfactori receptor antenn olfactori receptor neuron inform integr sens temperatur humid well vision process brain behavior output lead host find knowledg human scent compon unveil varieti odor attract mosquito also odor trigger repel find way divert human seek behavior femal mosquito use odor possibl mitig mosquito born pathogen transmiss | D009033;D000072777 | T204;T055 |
34,674,962 | androgen therapi women menopaus androgen essenti hormon women yet androgen therapi understudi underutil despit show improv postmenopaus hypoact sexual desir disord hsdd genitourinari syndrom menopaus gsm addit regulatori concern left signific gap commerci avail testosteron prepar formul specif women countri led label use male formul compound therapi regul beyond hsdd gsm testosteron like influenc brain breast cardiovascular musculoskelet system effect well studi therefor difficult counsel patient testosteron therapi use endpoint ultim studi need elucid effect creat fuller pictur risk benefit encourag product develop specif design women | D000728;D020018 | T039;T121;T048;T125 |
34,674,961 | dynam metabol engin escherichia coli improv ferment product pyruv deriv pyruv key intermedi involv various synthet metabol pathway microbi chemic fuel product wide use food chemic pharmaceut industri howev microbi product pyruv deriv compet microbi cell growth pyruv import metabol intermedi serv hub various endogen metabol pathway includ gluconeogenesi amino acid synthesi tca cycl fatti acid biosynthesi achiev effici bioprocess product pyruv deriv necessari reduc metabol imbal cell growth target chemic product purpos devis dynam metabol engin strategi within escherichia coli model metabol toggl switch mts employ redirect metabol flux endogen pathway toward target synthet pathway combin tca cycl interrupt mts reduct pyruv consumpt endogen pathway achiev drastic improv mm fold pyruv product addit demonstr redirect metabol flux excess pyruv toward isobutanol product final isobutanol product titer strain harbor mts improv compar control strain | D029968;D060847 | T116;T063 |
34,674,960 | intern radial perfus bioreactor promot decellular recellular rat uterin tissu advanc infertil treatment technolog vitro fertil ivf help mani infertil women abl get pregnant howev infertil treatment appli women suffer absolut uterin factor fabric function scaffold tissu engin approach believ play import role uterin regener uterus replac treat absolut uterin factor infertil research develop intern radial perfus bioreactor promot decellular recellular fabric function engin uterin tissu result dna content decellular uterin tissu high hydrostat pressur follow day intern perfus wash decreas compar nativ tissu collagen proteoglycan content pressur uterin tissu intern perfus bioreactor static control shake treatment high hydrostat pressur show signific chang compar nativ tissu newli develop perfus bioreactor also enabl recellular decellular tissu statist signific increas dna compar non seed cell group vimentin diamidino phenylindol dapi homogen express seed endometri stromal cell recellular tissu fabric use bioreactor develop intern radial perfus bioreactor first group success recellular uterin tissu layer includ epithelium endometrium myometrium result show intern perfus bioreactor potenti util fabric function engin tissu promot tissu regener | D007247;D054457 | T033;T047;T122;T046 |
34,674,958 | attenu virul multipl serotyp group streptococcus loss secret esteras group streptococcus gas produc streptococc secret esteras sse inhibit neutrophil recruit site infect crucial gas pathogenesi effect esteras sse hydrolyz sn ester bond human platelet activ factor inactiv abolish abil recruit neutrophil | D004950;D013290 | T116;T047;T126 |
34,674,955 | cardiac implant electron devic reoper compet risk death use cardiac implant electron devic cie includ pacemak implant cardiovert defibril icd cardiac resynchronis therapi pacemak crt p cardiac resynchronis therapi defibril crt increas past year lack real world evid longev devic older popul essenti inform health care deliveri support clinic decis | D058406;D017147 | T074;T061 |
34,674,954 | factor influenc women decis infant feed integr review mani women stop breastfeed earlier intend prior birth although mani studi focus factor influenc women antenat breastfeed decis factor influenc women decis continuum antenat postnat period less known | D008880;D009732 | T097;T091;T058 |
34,674,952 | predictor discharg time unplan readmiss laparoscop liver resect aim studi determin predictor discharg time day unplan readmiss laparoscop liver resect llr | D015179;D010535 | T061;T191;T060 |
34,674,951 | multi center post market clinic studi confirm safeti perform purastat manag bleed open liver resect purastat non bioactiv haemostat agent demonstr efficaci number differ surgic procedur perform prospect multi centr post market studi evalu efficaci safeti purastat liver resect perform metastat tumor | D006490 | T121 |
34,674,950 | preoper glan penil dimens differ hypospadia grade report glan penil dimens consecut boy hypospadia | D007021 | T019 |
34,674,948 | ct base radiom predict develop macrovascular invas hepatocellular carcinoma multicent studi macrovascular invas mavi occur near half hepatocellular carcinoma hcc patient diagnosi follow caus sever diseas deterior limit possibl surgic approach studi aim investig whether comput tomographi ct base radiom analysi could help predict develop mavi hcc | D006528;D008113 | T191 |
34,674,946 | effect mild heat exposur fatigu respons two set repeat sprint match initi mechan output examin whether mild heat exposur alter perform perceptu respons neural drive quadricep two set repeat sprint match initi mechan output | D006358;D052097 | T070;T023 |
34,674,945 | radiograph report style prefer referr district general hospit west midland england uk mani articl guidelin publish propos suggest optim radiolog report style like differ referr prefer differ style owe number clinic variabl aim studi assess x ray report style prefer referr district general hospit | D003952;D006769 | T073;T093;T060 |
34,674,944 | activ chlorhexidin acet combin fluconazol suspens biofilm candida auri newli emerg pathogen candida auri spread rapid caus serious invas infect candida auri often appear high resist classic antifung drug drug combin therapi emerg effect well establish strategi reliev drug resist problem object present work examin activ fluconazol combin chlorhexidin acet candida auri isol | D002175;D015725 | T004;T121;T109 |
34,674,943 | comparison live birth rate ivf embryo transfer without preimplant genet test aneuploidi use preimplant genet test aneuploidi pgt result higher live birth rate compar fresh frozen embryo transfer fet util pgt | D000782;D004624;D005307;D005820;D050498;D019836 | T049;T010;T025;T061;T060;T058;T033;T059 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.